NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

DRUG CONTROL AUTHORITY MEMBERS (2023 –2025)

Ex-officio members
01

YBhg. Datuk Dr. Muhammad Radzi bin Abu Hassan

Director General of Health
02


Senior Director of Pharmaceutical Services
03

YBrs. Dr. Azuana binti Ramli

Director National Pharmaceutical Regulatory Agency (NPRA)
DCA Secretary
04

YBrs. Puan Rosliza binti Lajis

Deputy Director, Centre of Product and Cosmetic Evaluation, NPRA

Other DCA Members

No.

ANGGOTA

ANGGOTA SILIH GANTI

1.

Dr. Zamri bin Mohamed 

Hospital Sultanah Nur Zahirah, Terengganu

Dr. Katrina Lau Kieng Huong

Hospital Tengku Ampuan Rahimah, Klang

2.

Puan Wan Noraimi binti Wan Ibrahim

Program Perkhidmatan Farmasi Kementerian Kesihatan Malaysia

3.

Dr. Nur Hidayah Kaz binti Abdul Aziz
Universiti Sains Malaysia,
Pulau Pinang.

Dr. Amirah binti Mohd Gazzali          Universiti Sains Malaysia,
Pulau Pinang.

4.

Prof. Dr. Hasniza binti Zaman Huri

Universiti Malaya, Kuala Lumpur

Prof. Madya Dr. Baharudin bin Ibrahim

Universiti Malaya, Kuala Lumpur

5.

Prof. Dr. Mohd bin Makmor Bakry Universiti Kebangsaan Malaysia,
Kuala Lumpur.

Prof. Madya Dr. Norazrina binti Azmi Universiti Kebangsaan Malaysia,
Kuala Lumpur.

6.

Dr. Nor Hayati binti Ali

Hospital Selayang, Selangor

Dr. Choong Swee Hsia

Hospital Pulau Pinang

7.

Datuk Dr. Thirunavukarasu Rajoo Malaysian Medical Association

Dr. Sivanaesan a/l Letchumanan
Malaysian Medical Association

8.

Dr. Rohaya binti Mohd. Ali

Jabatan Perkhidmatan Veterinar, Kementerian Pertanian Dan Keterjaminan Makanan

Dr. Adam Abdullah Kwan

Jabatan Perkhidmatan Veterinar, Kementerian Pertanian Dan Keterjaminan Makanan

NOMINATION CRITERIA FOR THE DRUG CONTROL AUTHORITY (DCA) EXPERT ADVISOR PANEL

NOMINATION CRITERIA FOR THE DRUG CONTROL AUTHORITY (DCA) EXPERT ADVISOR PANEL
 
  1. Criteria for nominating the Drug Control Authority (DCA) Expert Advisor Panel are as follows:
    1. Chief of Clinical Services of Ministry of Health (MOH) and/or Chairman of the Drug Working Committee (JKK) of MOH
      1. Not among the members/alternate members of DCA
    2. Consultant Specialists/ Senior Consultant Specialists/ Research Specialists from MOH nominated by the Medical Development Division or other relevant divisions/institutes
      1. At least 5-10 specialists for each area/sub-area of expertise;
      2. Must have at least 2 years of service with MOH remaining;
      3. Not among the Chief of Clinical Services of MOH or the Chairman of the Drug Working Committee (JKK) of MOH
      4. Not among the members/alternate members of DCA

    3. Consultant Specialists/ Senior Consultant Specialists from universities with teaching hospitals, and nominations will be requested from Hospital Universiti Sains Malaysia (HUSM), Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM), Pusat Perubatan Universiti Malaya (PPUM)
      1. At least 2-3 specialists for each area/sub-area of expertise;
      2. Must have at least 2 years of service with the Ministry of Higher Education remaining;
      3. Not among the members/alternate members of DCA

    4. Consultant Specialists/ Senior Consultant Specialists from the private sector
      1. At least 2-3 specialists for area/sub-area of expertise;
      2. Must possess relevant professional qualifications and experience;
      3. Must have retired from the Public Service
      4. Should have good record in providing product reviews previously

    5. Consultant Specialists/ Senior Consultant Specialists/ Veterinary Research Specialists from universities with veterinary teaching hospitals/clinics, and nominations will be requested from the Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM) and the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan (UMK)
      1. At least 1-2 specialists for each area/sub-area of expertise;
      2. Must have at least 2 years of service with the Ministry of Higher Education remaining;
      3. Not among the members/ alternate members of DCA
 
  1. All members of DCA Expert Advisor Panel are appointed by the Director General of Health for a term of 3 years.
 
  1. The criteria for the nomination of the existing DCA Expert Advisor Panel are based on the decisions of the following meetings:
  • 315th DCA Meeting, 29th August 2017
  • 358th DCA Meeting, 4th June 2021
  • 369th DCA Meeting, 10th February 2022

If there are any prospective panel members interested in becoming a panel member, they may contact Puan Suhailah Abu Bakar (e-mel: suhailah@npra.gov.my; No. Tel: 03-7883 5580) or Puan Aiza Adlina Abdullah (e-mel:aizaadlina@npra.gov.my; No. Tel: 03-7883 5466)

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Wednesday 02 April 2025, 11:58:42.

Search

Main Menu English